Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
| Image |  |
|---|---|
| Description | scientific article published on 12 September 2016 |
| Author/s |
author: Amr Shaaban Hanafy |
| Publication date | December 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |